MicroRNAs in pathophysiology of renal disease: An increasing interest;MicroARN et maladies rénales

Medecine/Sciences

Volumn 27, Issue 4, 2011, Pages 398-404

  Amrouche, Lucile ^a,b   Bonifay, Raja ^a,b   Anglicheau, Dany ^a,b  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; RIBONUCLEASE III;

ADAPTIVE IMMUNITY; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELLULAR IMMUNITY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; GENETICS; GRAFT REJECTION; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; HUMAN; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RNA PROCESSING; RNA STABILITY;

ADAPTIVE IMMUNITY; ANIMALS; BIOLOGICAL MARKERS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GRAFT REJECTION; HOMEOSTASIS; HUMANS; IMMUNITY, CELLULAR; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MICE; MICRORNAS; MODELS, BIOLOGICAL; RIBONUCLEASE III; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY;

EID: 79955606557     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011274016     Document Type: Article

References (49)

1. Hartmann C, Corre-Menguy F, Boualem A, et al. Les microARN: une nouvelle classe de régulateurs de l'expression génique. Med Sci Paris 2004; 20: 894-898. (Pubitemid 39387604)
2. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773. (Pubitemid 40292988)
3. Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
4. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-1414. (Pubitemid 46970709)
5. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166.
6. Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res 2004; 32: e188.
7. Pastorelli LM, Wells S, Fray M, et al. Genetic analyses reveal a requirement for Dicer1 in the mouse urogenital tract. Mamm Genome 2009; 20: 140-151.
8. Sequeira-Lopez ML, Weatherford ET, Borges GR, et al. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol 2010; 21: 460-467.
9. Elvira-Matelot E, Zhou XO, Farman N, et al. Regulation of WNK1 expression by miR-192 and aldosterone. J Am Soc Nephrol 2010; 21: 1724-1731.
10. Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 2008; 19: 2150-2158.
11. Ho J, Ng KH, Rosen S, et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 2008; 19: 2069-2075.
12. Shi S, Yu L, Chiu C, et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 2008; 19: 2159-2169.
13. Ho JJ, Marsden PA. Dicer cuts the kidney. J Am Soc Nephrol 2008; 19: 2043-2046.
14. Shi S, Yu L, Sun Y, et al. Exploration of the roles for miR-30 family in podocytopathies. J Am Soc Nephrol 2008; 19: 2159-2169.
15. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009; 106: 5330-5335.
16. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12. (Pubitemid 38020692)
17. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601. (Pubitemid 351627379)
18. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104: 3432-3437. (Pubitemid 46364176)
19. Krupa A, Jenkins R, Luo DD, et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 438-447.
20. Wang B, Herman-Edelstein M, Koh P, et al. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010; 59: 1794-1802.
21. O'Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
22. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009; 136: 26-36.
23. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486. (Pubitemid 44267285)
24. Zhou B, Wang S, Mayr C, et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007; 104: 7080-7085. (Pubitemid 47186012)
25. Koralov SB, Muljo SA, Galler GR, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860-874. (Pubitemid 351312808)
26. Cobb BS, Hertweck A, Smith J, et al. A role for dicer in immune regulation. J Exp Med 2006; 203: 2519-2527. (Pubitemid 44664621)
27. Jeker LT, Bluestone JA. Small RNA regulators of T cell-mediated autoimmunity. J Clin Immunol 2010; 30: 347-357.
28. Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses. cell 2010; 142: 914-929.
29. Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. lupus 2007; 16: 939-946.
30. Tang Y, Luo X, Cui H, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-1075.
31. Te JL, Dozmorov IM, Guthridge JM, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 2010; 5: e10344.
32. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation 2010; 90: 105-112.
33. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
34. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3: e3148.
35. Rood IM, Deegens JK, Merchant ML, et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 2010; 78: 810-816.
36. Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010; 78: 191-199.
37. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
38. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4: 721-726. (Pubitemid 47338166)
39. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
40. Agrawal S, Temsamani J, Galbraith W, et al. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995; 28: 7-16.
41. Lee SO, Masyuk T, Splinter P, et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 2008; 118: 3714-3724.
42. Xiao C, Srinivasan L, Calado DP, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405-414. (Pubitemid 351405110)
43. Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339-14344.
44. Liu W, Zabirnyk O, Wang H, et al. miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 2010; 29: 4914-4924.
45. Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. Faseb J 2008; 22: 4126-4135.
46. Kato M, Putta S, Wang M, et al. TGF-beta activates akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11: 881-889.
47. Park SM, Gaur AB, Lengyel E, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894-907. (Pubitemid 351482843)
48. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126-139.
49. Dunoyer P. La bataille du silence. Mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci Paris 2009; 25: 505-511.